| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rezolute, Inc. | CFO | Common Shares | 376K | $3.45M | $9.19 | 19 Nov 2025 | Direct |
| Rezolute, Inc. | CFO | Common Shares | 40K | $368K | $9.19 | 19 Nov 2025 | Held by PoC Capital LLC |
| Rezolute, Inc. | CFO | Common Shares | 23K | $211K | $9.19 | 19 Nov 2025 | Minor child #1 |
| Rezolute, Inc. | CFO | Common Shares | 20K | $184K | $9.19 | 19 Nov 2025 | Held by spouse |
| Rezolute, Inc. | CFO | Common Shares | 4.5K | $41.4K | $9.19 | 19 Nov 2025 | Held by minor child #2 |
| Rezolute, Inc. | CFO | Common Shares | 4.5K | $41.4K | $9.19 | 19 Nov 2025 | Held by minor child #3 |
| NEPHROS INC | CEO Specialty Renal Products | Common Stock | 8.95K | $19.7K | $2.20 | 27 May 2021 | By UTMA #1 |
| NEPHROS INC | CEO Specialty Renal Products | Common Stock | 8.67K | $19.1K | $2.20 | 27 May 2021 | By UTMA #2 |
| Rezolute, Inc. | CFO | Employee Stock Option (Right to Buy) | 63K | 19 Nov 2025 | Direct | ||
| NEPHROS INC | CEO Specialty Renal Products | Stock Option (Right to Buy) | 20K | 24 May 2021 | Direct | ||
| NEPHROS INC | CEO Specialty Renal Products | Common Stock Warrants (Right to Buy) | 0 | 24 May 2021 | By UTMA #1 | ||
| NEPHROS INC | CEO Specialty Renal Products | Common Stock Warrants (Right to Buy) | 0 | 24 May 2021 | By UTMA #2 |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | 19 Nov 2025 | 2 | $0 | 4 | CFO | 21 Nov 2025, 17:31 |
| RZLT | Rezolute, Inc. | 24 Jun 2025 | 1 | $20.3K | 4 | CFO | 24 Jun 2025, 12:41 |
| RZLT | Rezolute, Inc. | 10 Jun 2025 | 2 | $0 | 4 | CFO | 12 Jun 2025, 21:29 |
| RZLT | Rezolute, Inc. | 26 Mar 2025 | 2 | $57.7K | 4 | CFO | 28 Mar 2025, 08:40 |
| RZLT | Rezolute, Inc. | 16 Feb 2025 | 2 | $0 | 4 | CFO | 19 Feb 2025, 21:29 |
| RZLT | Rezolute, Inc. | 18 Dec 2024 | 1 | $42.9K | 4 | CFO | 18 Dec 2024, 18:01 |
| RZLT | Rezolute, Inc. | 12 Dec 2024 | 1 | $41.4K | 4 | CFO | 12 Dec 2024, 16:54 |
| RZLT | Rezolute, Inc. | 09 Dec 2024 | 1 | $53.2K | 4 | CFO | 10 Dec 2024, 09:11 |
| RZLT | Rezolute, Inc. | 23 Sep 2024 | 1 | $0 | 4 | CFO | 24 Sep 2024, 13:03 |
| RZLT | Rezolute, Inc. | 14 Jun 2024 | 1 | $162K | 4 | CFO | 14 Jun 2024, 12:06 |
| RZLT | Rezolute, Inc. | 29 May 2024 | 1 | $1.58K | 4 | CFO | 31 May 2024, 16:05 |
| RZLT | Rezolute, Inc. | 23 May 2024 | 2 | $9.67K | 4 | CFO | 28 May 2024, 14:48 |
| RZLT | Rezolute, Inc. | 15 Mar 2024 | 1 | $33.8K | 4 | CFO | 19 Mar 2024, 09:17 |
| RZLT | Rezolute, Inc. | 08 Mar 2024 | 1 | $96.3K | 4 | CFO | 08 Mar 2024, 12:37 |
| RZLT | Rezolute, Inc. | 16 Feb 2024 | 3 | $66.7K | 4 | CFO | 20 Feb 2024, 07:01 |
| RZLT | Rezolute, Inc. | 23 Jan 2024 | 1 | $0 | 4 | CFO | 25 Jan 2024, 12:47 |
| RZLT | Rezolute, Inc. | 22 Jan 2024 | 0 | $0 | 3 | CFO | 25 Jan 2024, 12:46 |
| NEPH | NEPHROS INC | 24 May 2021 | 2 | -$1.88K | 4/A | CEO Specialty Renal Products | 01 Jun 2021, 17:39 |